EPIVACS
Diana AlessandroEpidémiologie, Prévention, Immunité et Vaccins en Suisse Epidemiologie, Prävention, Immunität und Impfstoffe in der Schweiz Epidemiology, Prevention, Immunity and Vaccines in Switzerland
| Platform |  | Pricing | Freemium | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 98 | Founded | 5 years ago | Last Issue | 8 days ago |
| Active | Language |  French | |||
Read this Newsletter
dianaalessandro.substack.comLatest Issues
Tout commence parfois par un rongeur oublié au bout du monde.
Si vous ne deviez retenir qu’une chose de ce post : si vous n’étiez pas à bord du bateau ou en contact étroit avec une personne qui s’y trouvait, il n’y a aujourd’hui aucune raison particulière de s’inquiéter.
Mais cette histoire reste fa...
Faut-il recommencer une vaccination incomplète depuis zéro ?
C’est une situation qu’on rencontre régulièrement.
Un schéma vaccinal interrompu. Un intervalle trop long. Un doute.
Et cette question qui revient presque systématiquement :
“Faut-il recommencer toute la vaccination depuis le dé...
Êtes-vous protégé contre l’hépatite B ? 10 ou 100 UI/L, la réponse dépend du temps
Et vous, comment interprétez-vous un taux d’anti-HBs à 20 UI/L chez un-e étudiant-e professionnel-le de la santé vacciné-e récemment ?
Il existe, en pratique, une grande confusion autour du seuil d’anticorps anti-HBs considéré comme protec...
When Patients Ask for More Vaccines Than They Need
When saying “it’s not indicated” may not be enough
In the wake of the recent meningococcal B situation in the UK, I found myself encountering a pattern that we do not talk about often in clinical practice.
Méningocoque au Royaume-Uni : pourquoi tout le monde veut soudain se faire vacciner
Quand un risque rare devient tangible, notre manière de décider change, parfois plus que le risque lui-même.
Quelques cas de méningocoque B en Angleterre.
Audience Metrics
Subscribers, engagement, traffic and sponsorship for EPIVACS.
| Subscribers | Engagement | 68 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #137 |
Authors
The writers behind this newsletter.
Pédiatre et chargé d'enseignement intéressé à la pédagogie médicale
Social
Frequently Asked Questions
How can I access the email archive for EPIVACS?
You can find recent issues that have been published by EPIVACS on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does EPIVACS have?
To see how many people subscribe to EPIVACS, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in EPIVACS?
Newsletter advertising can be extremely effective when it's done right. Before you pitch EPIVACS as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like EPIVACS?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact EPIVACS using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to EPIVACS?
Scroll up to where it says Related Newsletters to see other publications like EPIVACS. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact EPIVACS?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.